SBC Medical (SBC) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
205.4M
Gross Profit
156.1M
75.97%
Operating Income
85.4M
41.56%
Net Income
46.7M
22.73%
EPS (Diluted)
$0.48
Balance Sheet Metrics
Total Assets
266.1M
Total Liabilities
71.1M
Shareholders Equity
195.0M
Debt to Equity
0.36
Cash Flow Metrics
Operating Cash Flow
42.1M
Free Cash Flow
17.2M
Revenue & Profitability Trend
SBC Medical Income Statement From 2022 to 2024
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 205.4M | 193.5M | 174.2M |
| Cost of Goods Sold | 49.4M | 56.2M | 59.3M |
| Gross Profit | 156.1M | 137.3M | 114.8M |
| Operating Expenses | 70.7M | 66.2M | 93.5M |
| Operating Income | 85.4M | 71.1M | 21.3M |
| Pre-tax Income | 73.5M | 73.6M | 23.7M |
| Income Tax | 26.8M | 35.0M | 18.1M |
| Net Income | 46.7M | 38.6M | 5.6M |
| EPS (Diluted) | $0.48 | $0.39 | $0.06 |
Income Statement Trend
SBC Medical Balance Sheet From 2022 to 2024
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Assets | |||
| Current Assets | 184.5M | 165.9M | 112.9M |
| Non-Current Assets | 81.6M | 92.9M | 112.5M |
| Total Assets | 266.1M | 258.8M | 225.5M |
| Liabilities | |||
| Current Liabilities | 61.2M | 92.5M | 101.3M |
| Non-Current Liabilities | 9.9M | 22.5M | 16.4M |
| Total Liabilities | 71.1M | 115.0M | 117.6M |
| Equity | |||
| Total Shareholders Equity | 195.0M | 143.8M | 107.9M |
Balance Sheet Composition
SBC Medical Cash Flow Statement From 2022 to 2024
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | 46.7M | 38.6M | 5.6M |
| Operating Cash Flow | 42.1M | 54.3M | -10.8M |
| Investing Activities | |||
| Capital Expenditures | -3.4M | -1.5M | -22.7M |
| Investing Cash Flow | -10.1M | 3.5M | -32.7M |
| Financing Activities | |||
| Dividends Paid | - | - | - |
| Financing Cash Flow | 22.9M | 6.1M | -8.0M |
| Free Cash Flow | 17.2M | 39.5M | -25.0M |
Cash Flow Trend
SBC Medical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
8.69
Forward P/E
0.40
Price to Book
1.91
Price to Sales
2.18
PEG Ratio
0.40
Profitability Ratios
Profit Margin
24.94%
Operating Margin
51.14%
Return on Equity
26.19%
Return on Assets
19.98%
Financial Health
Current Ratio
4.44
Debt to Equity
6.23
Beta
1.36
Per Share Data
EPS (TTM)
$0.48
Book Value per Share
$2.19
Revenue per Share
$2.00
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| sbc | 432.1M | 8.69 | 1.91 | 26.19% | 24.94% | 6.23 |
| Verisk Analytics | 42.5B | 44.72 | 345.42 | 468.22% | 33.13% | 3,178.84 |
| Equifax | 31.7B | 52.06 | 6.36 | 12.52% | 10.68% | 97.10 |
| Icf International | 1.5B | 14.42 | 1.60 | 11.64% | 5.45% | 71.13 |
| CRA International | 1.2B | 24.67 | 5.46 | 23.21% | 7.31% | 81.36 |
| Diginex | 973.3M | -196.87 | - | 21.17% | 0.00% | -0.92 |
Financial data is updated regularly. All figures are in the company's reporting currency.